Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome (Q38293858)

1 September 2017

Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

1 September 2017

0 references

1 reference

1 reference

Fusco A

1

1 reference

1 September 2017

Bianchi A

2

1 reference

1 September 2017

Mancini A

3

1 reference

1 September 2017

Milardi D

4

1 reference

1 September 2017

Giampietro A

5

1 reference

1 September 2017

Cimino V

6

1 reference

1 September 2017

Porcelli T

7

1 reference

1 September 2017

Romualdi D

8

1 reference

1 September 2017

Guido M

9

1 reference

1 September 2017

Lanzone A

10

1 reference

1 September 2017

Pontecorvi A

11

1 reference

1 September 2017

De Marinis L

12

1 reference

1 September 2017

1 December 2007

1 reference

Journal of Endocrinological Investigation

1 September 2017

1 reference

1 September 2017

30

1 reference

1 September 2017

11

1 reference

1 September 2017

948-956

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03349243

1 September 2017

0 references

cites work

Biological, physiological, and pharmacological aspects of ghrelin

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Neuroendocrine and Metabolic Effects of Acute Ghrelin Administration in Human Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Exploring the role of ghrelin as novel regulator of gonadal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Serum leptin concentrations in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Evidence for altered adipocyte function in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Circulating ghrelin levels in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Elevated ghrelin plasma levels in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Circulating ghrelin concentrations in the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Circulating leptin concentrations and ovarian function in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Insulin and cortisol promote leptin production in cultured human fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

The android woman--a risky condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349243

Influence of pyridostigmine on growth hormone (GH) response to GH-releasing hormone pre- and postprandially in normal and obese subjects

21 January 2018

1 reference

12 December 2020

Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

1 reference

12 December 2020

Ghrelin strongly stimulates growth hormone release in humans

1 reference

12 December 2020

Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia

1 reference

12 December 2020

Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.

1 reference

12 December 2020

Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome.

1 reference

12 December 2020

Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity

1 reference

12 December 2020

Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome

1 reference

12 December 2020

Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells

1 reference

12 December 2020

Serum leptin concentration, body composition, and gonadal hormones during puberty

1 reference

12 December 2020

Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients

1 reference

12 December 2020

Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.

1 reference

12 December 2020

The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia.

1 reference

12 December 2020

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

1 reference

12 December 2020

Leptin concentrations in the polycystic ovary syndrome

1 reference

12 December 2020

Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects

1 reference

12 December 2020

Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.

1 reference

12 December 2020

Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition

1 reference

12 December 2020

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features

1 reference

12 December 2020

Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome

1 reference

12 December 2020

Insulin regulates plasma ghrelin concentration

1 reference

12 December 2020

Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03349243

1 reference

1 September 2017

1 reference